![]() | ![]() |
Formats:
|
||||||||||||||||||
Copyright © 2006, American Society of Plant Biologists Distinct Domains in the ARC Region of the Potato Resistance Protein Rx Mediate LRR Binding and Inhibition of Activation[W] Boyce Thompson Institute for Plant Research, Ithaca, New York 14853 1To whom correspondence should be addressed. E-mail pm99/at/cornell.edu; fax 607-254-1242. Received March 22, 2006; Revised June 21, 2006; Accepted June 27, 2006. This article has been cited by other articles in PMC.Abstract Plant nucleotide binding and leucine-rich repeat (NB-LRR) proteins contain a region of homology known as the ARC domain located between the NB and LRR domains. Structural modeling suggests that the ARC region can be subdivided into ARC1 and ARC2 domains. We have used the potato (Solanum tuberosum) Rx protein, which confers resistance to Potato virus X (PVX), to investigate the function of the ARC region. We demonstrate that the ARC1 domain is required for binding of the Rx N terminus to the LRR domain. Domain-swap experiments with Rx and a homologous disease resistance gene, Gpa2, showed that PVX recognition localized to the C-terminal half of the LRR domain. However, inappropriate pairings of LRR and ARC2 domains resulted in autoactive molecules. Thus, the ARC2 domain is required to condition an autoinhibited state in the absence of elicitor as well as for the subsequent elicitor-induced activation. Our data suggest that the ARC region, through its interaction with the LRR, translates elicitor-induced modulations of the C terminus into a signal initiation event. Furthermore, we demonstrate that physical disruption of the LRR–ARC interaction is not required for signal initiation. We propose instead that this activity can lead to multiple rounds of elicitor recognition, providing a means of signal amplification. INTRODUCTION Race-specific, or gene-for-gene, resistance is a robust plant defense response whose initiation is dependent on the genotypes of both the host and the pathogen. The products of plant disease resistance (R) genes, known as R proteins, initiate this response when the appropriate elicitors, pathogen-encoded avirulence (Avr) gene products, are present (Flor, 1971; Keen, 1990). This response is often associated with a type of programmed cell death referred to as the hypersensitive response (HR) (Dangl et al., 1996; Hammond-Kosack and Jones, 1996). The type of R genes most prevalent in plant genomes encode proteins referred to as NB-LRR or NBS-LRR proteins because they contain a central nucleotide binding (NB) domain as well as a C-terminal leucine-rich repeat (LRR) domain. The NB domains of two NB-LRR proteins have been shown in vitro to bind and hydrolyze ATP (Tameling et al., 2002). The LRR domains of R proteins are highly divergent both in primary structure and number of repeats, appear to have undergone diversifying selection, and have been shown to be the region of the protein that confers recognition specificity (Meyers et al., 1998; Noel et al., 1999; Mondragon-Palomino et al., 2002). Between the NB and LRR domains is a well-conserved region of homology whose function is poorly understood. This region has been defined as the ARC domain because of its presence in Apaf-1, R proteins, and CED-4 (van der Biezen and Jones, 1998) and is found in members of the apoptotic ATPase family of STAND (for signal transduction ATPases with numerous domains) NTPases (Leipe et al., 2004). Given that the NB and ARC domains are contiguous, these domains are often referred to as the NB-ARC domain. Recent molecular modeling of the ARC domain of plant NB-LRR proteins based on the crystal structure of Apaf-1 suggests that this domain is composed of two separate structural units: an N-terminal helical bundle and a C-terminal winged helix domain, referred to as the ARC1 and ARC2 subdomains, respectively (Albrecht and Takken, 2006; McHale et al., 2006). Plant NB-LRR proteins can be divided into two classes based on the putative signaling domain present at the N terminus: those with an N-terminal TIR (for Toll and Interleukin-1 Receptor) homology domain and those without. The latter are identified by canonical motifs in the NB-ARC domain, and their N termini are often predicted to encode coiled-coil domains; thus, they are referred to as the CC class of NB-LRR proteins (Meyers et al., 1999; Cannon et al., 2002). The potato (Solanum tuberosum) protein Rx confers resistance to Potato virus X (PVX), with the PVX coat protein (CP) acting as the Avr determinant (Bendahmane et al., 1995). Rx is a typical CC-NB-LRR protein and, of characterized R proteins, is most closely related to the potato proteins Rx2 and Gpa2 and the pepper (Capsicum annuum) protein Bs2, which confer resistance to PVX, the nematode Globodera pallida, and the bacterium Xanthomonas campestris, respectively (Tai et al., 1999; Bendahmane et al., 2000; van der Vossen et al., 2000). Studies of the Rx and Bs2 proteins have demonstrated that expression of protein fragments consisting of either CC-NB-ARC plus LRR or CC plus NB-ARC-LRR reconstitutes the function of the full-length molecule in generating an elicitor-specific HR and that these same fragments undergo physical intramolecular interactions (Moffett et al., 2002; Leister et al., 2005). In the case of Rx, both of these interactions are disrupted in the presence of PVX CP. These disruptions likely play a role in R protein function; however, activation cannot be a simple matter of relieving a negative regulatory interaction, as physical removal of any of the domains does not lead to constitutive activation of the protein (Moffett et al., 2002). A number of studies have described amino acid substitutions in NB-LRR proteins that result in constitutive activation of resistance responses and/or programmed cell death in the absence of elicitor (Li et al., 2001; Bendahmane et al., 2002; Shirano et al., 2002; Noutoshi et al., 2005). These constitutive gain-of-function mutants are referred to as autoactivators. Autoactivating proteins have also been obtained by swapping amino acid sequence between closely related paralogues or alleles of the Rp-1, L, and Mi-1 NB-LRR proteins (Hwang et al., 2000; Sun et al., 2001; Howles et al., 2005). This autoactivation can occur by the inappropriate pairing of several different regions of these proteins, although it has not been well defined which regions must be intercompatible. We have investigated the role of the ARC domain in the regulation of the Rx protein. We show that the ARC1 subdomain plays a critical role in physically recruiting the LRR to the CC-NB-ARC. Domain-swap experiments between Rx and GPA2 demonstrate that pairing of at least two different regions of the Rx LRR with the GPA2 ARC2 subdomain resulted in autoactivation, suggesting that interplay between ARC2 and the LRR regulates the molecule's transition from an inactive to an active state. We suggest a model wherein recognition represents any event that results in a change at the interface between the ARC and LRR allowing this transition to take place. In addition, Rx/GPA2 swaps demonstrate that CP recognition specificity maps to the C terminus of the Rx LRR domain. We also present evidence that disruption of the interaction between the ARC and LRR by the CP is subsequent to, or coincident with, signal initiation and suggest that this disruption is required for multiple rounds of recognition, resulting in signal amplification. RESULTS Molecular Dissection of the Rx NB-ARC Domain Previous studies have shown that the P-loop/Kinase 1 (PL) and Kinase 2 (K2) motifs of the Rx NB domain, as well as the ARC motif GxP (often referred to as GLPL), are critical to Rx function (Bendahmane et al., 2002). To determine the importance of the various conserved motifs within the ARC domain of Rx, we replaced a number of residues with Ala, as indicated in red in Figure 1
Full-length Rx variants were transiently expressed under the control of the Rx genomic promoter (PRx) via agroinfiltration in Nicotiana benthamiana leaves together with either green fluorescent protein (GFP) or CP (Figure 2A
Rx is able to condition extreme resistance to PVX in the absence of cell death (Adams et al., 1986). To assess each variant's ability to confer viral resistance, we agroinfiltrated the various PRx:Rx constructs together with an infectious PVX:GFP clone (Peart et al., 2002). Full-length Rx prevents PVX:GFP accumulation, as does coexpression of either CC plus NB-ARC-LRR or CC-NB-ARC plus LRR (see Supplemental Figure 1 online). Interestingly, although the LE301/318AA and C328A substitutions were not obviously compromised in their ability to initiate an HR, they were compromised in their ability to fully suppress PVX accumulation. The inability of LE301/318AA to contain PVX:GFP is a result of the L301A mutation alone, as this substitution was compromised in PVX resistance, whereas E318A was not (data not shown). To assess whether the mutant CC-NB-ARC fragments were compromised in their ability to bind the Rx LRR, we performed coimmunoprecipitation experiments. We also included in this experiment three C-terminal deletions of CC-NB-ARC terminating at residues 457, 382, and 293, which correspond to deletion of the C terminus up to and including the MHD motif, the RNBS-D motif, and the entire ARC region, respectively. All of the CC-NB-ARC variants, tagged with a hemagglutinin (HA) epitope, were coexpressed in N. benthamiana leaves with 6XMyc-tagged Rx LRR (LRR:MYC). Upon immunoprecipitation with anti-Myc antibodies, we found that 1-457 and 1-382 plus all of the Ala-substituted CC-NB-ARC variants were able to bind the LRR, although the binding of many constructs appears to be somewhat compromised, possibly as a result of the reduced accumulation of these fragments (Figure 2B LRR–NB-ARC Physical Interactions Lack Specificity Previously, it was demonstrated that the CC-NB-ARC and LRR fragments of Rx and Bs2 were not functionally compatible and that the Bs2 LRR did not bind to the Rx CC-NB-ARC (Moffett et al., 2002). To further investigate this specificity, we tested the ability of the LRR and CC-NB-ARC fragments of Rx, Bs2, and the Arabidopsis thaliana HRT protein (Cooley et al., 2000) to interact with each other. Although in this study the interaction between the Bs2 LRR and Rx CC-NB-ARC was very weak, the other combinations of LRR and CC-NB-ARC fragments were found to coimmunoprecipitate, demonstrating that the interaction specificity between LRR and CC-NB-ARC fragments is not as stringent as suggested by the initial Bs2 LRR–Rx CC-NB-ARC experiments (Figure 3
Regions Required for LRR–CC-NB-ARC Compatibility and CP Recognition Initial experiments investigating recognition specificity showed that certain domain swaps between Rx and GPA2 produced autoactive chimeras. We generated a series of swaps to identify the regions of Rx and GPA2 that are incompatible with each other. An alignment between Rx and GPA2 revealed two regions that appear to be the most variable: the ARC domain and the C-terminal 237 residues (Figure 1
We found that exchange of regions A of Rx and GPA2 did not alter the CP-dependent HR phenotype of either molecule (Figure 4A Region DE of Rx was sufficient to mediate a CP-dependent HR as long as the appropriate ARC2 subdomain was present to prevent autoactivation (Figure 4C It is possible that some of the chimeric molecules do not function because of a lack of intramolecular interaction between the CC-NB-ARC and LRR fragments of the protein. To test this notion, we used an Rx LRR fragment containing the Y712H mutation. This mutation in the LRR domain causes an autoactive phenotype when present in full-length Rx (Farnham, 2003) as well as in the LRR plus CC-NB-ARC complementation assay (Figure 4D Disruption of the LRR–ARC Interaction Is Not Required for Signal Initiation We demonstrated previously that the Rx LRR binds CC-NB-ARC in the absence, but not in the presence, of CP, suggesting that the release of the LRR is an important step in Rx signaling (Moffett et al., 2002). We thus predicted that autoactivating mutations in Rx would compromise the interaction between these fragments. To test this idea, we introduced the autoactivating D460V mutation (Bendahmane et al., 2002) into the CC-NB-ARC:HA construct and the Y712H mutation into an LRR construct with a FLAG epitope and 6×His tags (LRR:FH). We also tested the autoactivating combination of the GPA2 CC-NB-ARC:HA plus the Rx LRR:FH. To prevent an HR, we introduced inactivating mutations into the CC-NB-ARC versions of Rx and GPA2 in the P-loop (PL; GK175AA) and Kinase 3a motifs (K3; L270P), respectively. We found that LRR:FH coimmunoprecipitated CC-NB-ARC:HA regardless of whether or not one of the fragments contained an autoactivating mutation (Figure 5A
Additional evidence that LRR disruption is not required for signal initiation is provided by the RR-GRR construct. The RR-GRR chimera has the ability to confer a CP-dependent HR (Figure 4C Molecular Dissection of the LRR Domain The Rx LRR domain has been shown to bind CC-NB-ARC and to be essential for the HR elicited either by CP or by autoactivating mutations (Moffett et al., 2002). To determine whether we could delimit regions of the LRR domain necessary or sufficient for CC-NB-ARC binding and/or signaling, we generated HA-tagged LRR constructs that were deleted from either the N or C terminus of the domain. C-terminal deletions were generated that terminated at residues 904, 871, and 734, corresponding to removal of the acidic tail, all sequence C terminal to the last predicted LRR, and all sequence C terminal to LRR 11, respectively, as annotated previously (Bendahmane et al., 1999). N-terminal deletions begin at residue 497 (LRR 2), 529 (LRR 4), 578 (LRR 6), 617 (LRR 7), and 723 (LRR 12). Constructs lacking either the acidic tail or the first LRR were functional in complementing CC-NB-ARC (Figure 6A
DISCUSSION Molecular Functions of the ARC Region of Homology Motifs within the ARC region of homology are well conserved among plant NB-LRR proteins as well as other members of the apoptotic-ATPase clade of STAND NTPases, including Apaf-1 and CED-4 (van der Biezen and Jones, 1998; Leipe et al., 2004). Recent modeling based on Apaf-1 suggests that this region actually contains two structural subdomains termed ARC1 and ARC2 (Albrecht and Takken, 2006; McHale et al., 2006). The junction between ARC1 and ARC2 corresponds roughly to the region immediately N terminal to the highly conserved SY motif (or motif 2) (van der Biezen and Jones, 1998) of Rx and thus corresponds well with the two regions that we have defined functionally. We show that the ARC1 subdomain of Rx is necessary for the physical interaction between the N terminus of the protein and the LRR domain (Figure 2B For the most part, mutation of even the most conserved residues within the ARC domain appears to have only a quantitative effect on LRR binding (Figure 2B The physical binding between the LRR and ARC domains of distantly related R proteins does not result in functional molecules (Moffett et al., 2002; Leister et al., 2005). At the same time, this and other studies (Hwang et al., 2000; Hwang and Williamson, 2003; Howles et al., 2005) illustrate that compatibility between protein domains is often necessary to retain chimeras of closely related R proteins in an inactive state. Combining the GPA2 region B (ARC2 subdomain) with region C, DE, or E of the Rx LRR resulted in a constitutively active molecule. The ARC2 subdomain contains the MHDV motif, and mutation of the highly conserved Asp in this motif in several NB-LRR proteins results in a strong autoactivation phenotype (Bendahmane et al., 2002; de la Fuente van Bentem et al., 2005; Howles et al., 2005). Deletion of the last 15 amino acids of the CC-NB-ARC, up to and including the MHDV motif, results in an inactive molecule, and Ala substitution of this motif compromises Rx function (Figure 2A Domain-swap experiments with Mi1.2 and Mi1.1 demonstrated autoactivating incompatibilities between the LRRs of Mi1.2 and a region of 751 residues encompassing the entire NB-ARC domain (Hwang et al., 2000). This allows for the possibility that it is the Mi1.1 ARC2 subdomain that conditions inappropriate signaling in the presence of the Mi1.2 LRRs. An apparent autoactivating phenotype is also correlated with LRR exchange between homologs at the maize (Zea mays) Rp1 locus (Sun et al., 2001). The authors of that study note that RP1 homologs possess a hypervariable region immediately preceding the MHDV motif that can also be seen in the Rx/Rx2/GPA2 family and the RPP8/HRT/RCY-1 locus (Bendahmane et al., 2000; Takahashi et al., 2002). In the crystal structure of Apaf-1, the P-loop, Kinase 2, Kinase 3a, and GxP motifs are all located in the same ADP binding pocket (Riedl et al., 2005), and mutations in any of these motifs caused complete loss of function of Rx (or GPA2 in the case of Kinase 3a). Surprisingly, with the exception of the RNBS-D substitution, mutation of other highly conserved residues within the ARC domain of full-length Rx did not fully compromise the CP-dependent HR (Figure 2A Some mutants, such as LE301/318AA and C328A, were able elicit a CP-dependent HR indistinguishable from wild-type Rx but were compromised in conferring extreme resistance to PVX:GFP in a transient assay (Figure 2A Role of CP-Mediated Disruption of the LRR–ARC Interaction We have shown that binding of CC-NB-ARC by the LRR is not affected by autoactivating mutations, nor is the CP-dependent disruption of this binding (Figure 5 Our results do not directly address the dynamics of ATP binding or hydrolysis. However, as the CP-mediated disruption of the interaction between ARC and LRR takes place in the presence of a P-loop mutation (Moffett et al., 2002), the recognition might occur independent of nucleotide binding and downstream signaling. We propose that the cycle of disruption and reassociation would allow the protein to return to its initial state after a signal initiation event and undergo further rounds of recognition. This, in turn, would allow for multiple rounds of activation and the associated events that take place within the nucleotide binding pocket. The bacterially produced NB-ARC domains of I-2 and Mi-1 have been shown to hydrolyze ATP in vitro (Tameling et al., 2002). The proteins used in the latter study lacked LRR domains, and given the importance of the LRR domain for activity as well as recognition (Figure 5B The Rx C Terminus Conditions Recognition Specificity Sequence swaps between Rx and GPA2 also allowed us to identify the region of Rx that determines recognition specificity. Because much of the variation between the Rx and GPA2 proteins is found in the ARC domain and in the LRR C terminus, we hypothesized that the recognition determinants would lie in one of these two regions. Accordingly, constructs containing Rx region DE (amino acids 701 to 937) condition CP-dependent HR similar to Rx. Region B (ARC2) did not appear to contribute to CP recognition but was required to avoid autoactivation in the presence of Rx LRR sequences (Figure 4C Implications for Recognition and Activation It is tempting to speculate that the many autoactivating point mutations found in NB-LRR proteins disrupt negative regulatory regions of the protein. However, in domain-swap experiments, autoactivation occurs when wild-type domains are placed in an inappropriate context. Furthermore, autoactivating fusions can be obtained by exchanging different, nonoverlapping Rx LRR sequences for the equivalent region of GPA2. Autoactivating mutations found in human NOD-LRR proteins are numerous and map throughout the proteins in both conserved and nonconserved residues (Tanabe et al., 2004; Ting and Davis, 2005; Rairdan and Moffett, 2006). We propose that NB-LRR proteins are normally present in the cell in a conformation that is autoinhibited from progressing to an active state by virtue of a perfect fit between the ARC and LRR domains but that this inactive state is a hair trigger that is highly sensitive to perturbation. At least one mechanism to overcome this inactive state is to alter the interface between the ARC and LRR domains through an elicitor-induced conformational change of the LRR. Autoactive chimeras might mimic this process if the resulting interaction between the ARC and LRR domains no longer forms a perfect fit and the resulting interface lacks the structural constraint to prevent the molecule from progressing to its active conformation. The ARC2 subdomain appears to be involved in both activation and autoinhibition. Thus, we envisage a mechanism whereby elicitor recognition by the LRR alters the interface between the LRR and ARC2 domains and repositions critical residues such that the NTP binding and/or hydrolysis activity of the protein is altered, leading to signal initiation, as has been suggested previously (Moffett et al., 2002; Tameling et al., 2006). Such a model is presented in Figure 7
Given that activation can occur either by recognition or by multiple amino acid substitutions, we suggest that elicitor recognition results in a perturbed LRR domain (Figure 7 METHODS Plasmid Construction The pBIN61-based vectors with HA, FLAG plus 6×His (FH), and six c-Myc (MYC) epitope tags, as well as mutations in the Rx P-loop (GK175AA), Kinase 2 (DD244AA), and GxP (GLPL330ALAL) motifs, Rx 1-382, Rx 1-293, Rx LRR, Rx CC-NB-ARC (previously designated CC-NBS), Bs2 LRR, Bs2 CC-NB-ARC, and Rx CC-NB-ARC(D460V) have been described (Bendahmane et al., 2002; Moffett et al., 2002). The Rx 1-452 deletion construct was generated using the same strategy as for the other deletion constructs (Bendahmane et al., 2002). All site-directed mutants or Rx/GPA2 fusions described here were generated with extension-overlap PCR (Vallejo et al., 2003) using KOD high-fidelity thermostable polymerase according to the manufacturer's instructions (Novagen). All site-directed mutants had the same start and termination sites as the wild-type constructs. The GPA2 CC-NB-ARC was generated using the same primers as the Rx CC-NB-ARC construct (Bendahmane et al., 2002), and the K3 mutation was identified as a PCR error resulting in the mutation L270P. N-terminal LRR deletions incorporated a start codon before the first LRR residue described in each deletion in Figure 6 Agrobacterium-Mediated Transient Expression (Agroinfiltration) Binary vectors were transformed into Agrobacterium tumefaciens strain C58C1 carrying the virulence plasmid pCH32. Agroinfiltration was performed as described (Bendahmane et al., 2000) at OD600 = 0.2. HR phenotypes generally presented at 24 to 48 h. The PVX:GFP resistance assay consisted of agroinfiltrating Rx variants at OD600 = 0.2 with Agrobacterium GV3101 carrying the plasmid pGr208, which expresses the PVX:GFP cDNA (Peart et al., 2002) at OD600 = 0.001. GFP fluorescence was monitored 5 d later using a handheld UV lamp. Immunoprecipitation and Immunoblotting Protein extracts from agroinfiltrated N. benthamiana leaves were prepared by grinding 1 g of leaf tissue in 2.5 mL of extraction buffer (25 mM Tris-HCl, pH 7.5, 1 mM EDTA, 150 mM NaCl, 10% glycerol, and 5 mM DTT) in the presence of plant protease inhibitor cocktail (Sigma-Aldrich) and 2% polyvinylpolypyrrolidone. Extracts were spun at 12,000g at 4°C for 15 min, and 1 mL of extract was subsequently passed through a 5-mL Sephadex G-25 spin column (preequilibrated with extraction buffer). Immunoprecipitation was performed as follows: 400 to 800 μL of extract in a total volume of 1400 μL of extraction buffer plus 0.15% Nonidet P-40 (immunoprecipitation buffer) was precleared with 50 μL of IgG agarose (Sigma-Aldrich) at 4°C for 30 min. Extracts were spun for 2 min at 12,000g, and the supernatant was added to 25 μL of anti-HA conjugated agarose beads from either Roche (3F10) or Sigma-Aldrich (HA-7), anti-FLAG (M2; Sigma-Aldrich) agarose beads, or anti-Myc (9E10; Sigma-Aldrich) agarose beads. Extracts were incubated end over end at 4°C for 1 h and washed four times with immunoprecipitation buffer, and the pellet was resuspended in 1× SDS-PAGE loading buffer. Immunoprecipitated samples were separated by SDS-PAGE and blotted to Immun-Blot polyvinylidene difluoride membranes (Bio-Rad). Blots were preblocked with 5% skim milk powder in Tris-buffered saline plus Tween 20 and probed with 40 to 200 ng/mL antibody in Tris-buffered saline plus Tween 20. HA epitope tags were detected with 3F10 (Roche), and Myc tags were detected with either 9E10 or A-14 (Santa Cruz Biotechnology), followed by washing and incubation with an appropriate horseradish peroxidase–conjugated secondary antibody. FLAG epitope tags were detected with horseradish peroxidase–conjugated M2 antibody (Sigma-Aldrich). Proteins were visualized with ECL-Plus (Amersham). Accession Numbers Supplemental Data The following materials are available in the online version of this article.
[Supplemental Data]
Acknowledgments We thank Melanie Sacco, Greg Martin, and David Baulcombe for critical review of the manuscript and the Boyce Thompson Institute greenhouse staff for plant care. We are grateful to Garry Farnham for the Rx(Y712H) mutant, to Dan Klessig for the HRT cDNA, and to Diana Taft for technical assistance. Funding for this work was provided by the National Science Foundation (Grant IOB-0343327) and The Triad Foundation. We are also grateful for financial support during preliminary stages of this work from the Biotechnology and Biological Sciences Research Council and the Sainsbury Laboratory (supported by the Gatsby Charitable Foundation). Notes The author responsible for distribution of materials integral to the findings presented in this article in accordance with the policy described in the Instructions for Authors (www.plantcell.org) is: Peter Moffett (pm99/at/cornell.edu). [W]Online version contains Web-only data. Article, publication date, and citation information can be found at www.plantcell.org/cgi/doi/10.1105/tpc.106.042747. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||
Annu Rev Genet. 1990; 24():447-63.
[Annu Rev Genet. 1990]Plant Cell. 1996 Oct; 8(10):1793-1807.
[Plant Cell. 1996]Plant Cell. 1996 Oct; 8(10):1773-91.
[Plant Cell. 1996]Plant Cell. 2002 Nov; 14(11):2929-39.
[Plant Cell. 2002]Plant Cell. 1998 Nov; 10(11):1817-32.
[Plant Cell. 1998]Curr Biol. 1998 Mar 26; 8(7):R226-7.
[Curr Biol. 1998]J Mol Biol. 2004 Oct 8; 343(1):1-28.
[J Mol Biol. 2004]Biochem Biophys Res Commun. 2006 Jan 13; 339(2):459-62.
[Biochem Biophys Res Commun. 2006]Genome Biol. 2006; 7(4):212.
[Genome Biol. 2006]Plant J. 1999 Nov; 20(3):317-32.
[Plant J. 1999]J Mol Evol. 2002 Apr; 54(4):548-62.
[J Mol Evol. 2002]Plant J. 1995 Dec; 8(6):933-41.
[Plant J. 1995]Proc Natl Acad Sci U S A. 1999 Nov 23; 96(24):14153-8.
[Proc Natl Acad Sci U S A. 1999]Plant J. 2000 Jan; 21(1):73-81.
[Plant J. 2000]Plant J. 2000 Sep; 23(5):567-76.
[Plant J. 2000]EMBO J. 2002 Sep 2; 21(17):4511-9.
[EMBO J. 2002]Plant Cell. 2005 Apr; 17(4):1268-78.
[Plant Cell. 2005]Mol Plant Microbe Interact. 2001 Oct; 14(10):1131-9.
[Mol Plant Microbe Interact. 2001]Plant J. 2002 Oct; 32(2):195-204.
[Plant J. 2002]Plant Cell. 2002 Dec; 14(12):3149-62.
[Plant Cell. 2002]Plant J. 2005 Sep; 43(6):873-88.
[Plant J. 2005]Plant Cell. 2000 Aug; 12(8):1319-29.
[Plant Cell. 2000]Plant J. 2002 Oct; 32(2):195-204.
[Plant J. 2002]Curr Biol. 1998 Mar 26; 8(7):R226-7.
[Curr Biol. 1998]Plant Cell. 1999 May; 11(5):781-92.
[Plant Cell. 1999]Plant J. 2002 Oct; 32(2):195-204.
[Plant J. 2002]Plant J. 2002 Mar; 29(5):569-79.
[Plant J. 2002]Biochem Biophys Res Commun. 2006 Jan 13; 339(2):459-62.
[Biochem Biophys Res Commun. 2006]EMBO J. 2002 Sep 2; 21(17):4511-9.
[EMBO J. 2002]Plant Cell. 2000 May; 12(5):663-76.
[Plant Cell. 2000]Plant Cell. 2005 Apr; 17(4):1268-78.
[Plant Cell. 2005]Biochem Biophys Res Commun. 2006 Jan 13; 339(2):459-62.
[Biochem Biophys Res Commun. 2006]EMBO J. 2002 Sep 2; 21(17):4511-9.
[EMBO J. 2002]Plant J. 2002 Oct; 32(2):195-204.
[Plant J. 2002]Plant Cell. 2005 Apr; 17(4):1268-78.
[Plant Cell. 2005]EMBO J. 2002 Sep 2; 21(17):4511-9.
[EMBO J. 2002]Plant Cell. 1999 May; 11(5):781-92.
[Plant Cell. 1999]Curr Biol. 1998 Mar 26; 8(7):R226-7.
[Curr Biol. 1998]J Mol Biol. 2004 Oct 8; 343(1):1-28.
[J Mol Biol. 2004]Biochem Biophys Res Commun. 2006 Jan 13; 339(2):459-62.
[Biochem Biophys Res Commun. 2006]Genome Biol. 2006; 7(4):212.
[Genome Biol. 2006]Plant Cell. 2002 Nov; 14(11):2929-39.
[Plant Cell. 2002]EMBO J. 2002 Sep 2; 21(17):4511-9.
[EMBO J. 2002]Plant Cell. 2005 Apr; 17(4):1268-78.
[Plant Cell. 2005]Plant Cell. 2000 Aug; 12(8):1319-29.
[Plant Cell. 2000]Plant J. 2003 Jun; 34(5):585-93.
[Plant J. 2003]Mol Plant Microbe Interact. 2005 Jun; 18(6):570-82.
[Mol Plant Microbe Interact. 2005]Plant Cell. 2000 Aug; 12(8):1319-29.
[Plant Cell. 2000]Genetics. 2001 May; 158(1):423-38.
[Genetics. 2001]Plant J. 2000 Jan; 21(1):73-81.
[Plant J. 2000]Plant J. 2002 Dec; 32(5):655-67.
[Plant J. 2002]Nature. 2005 Apr 14; 434(7035):926-33.
[Nature. 2005]EMBO J. 2002 Sep 2; 21(17):4511-9.
[EMBO J. 2002]Plant Cell. 2005 Apr; 17(4):1268-78.
[Plant Cell. 2005]Annu Rev Phytopathol. 2005; 43():581-621.
[Annu Rev Phytopathol. 2005]EMBO J. 2002 Sep 2; 21(17):4511-9.
[EMBO J. 2002]Plant Cell. 2002 Nov; 14(11):2929-39.
[Plant Cell. 2002]Plant Physiol. 2006 Apr; 140(4):1233-45.
[Plant Physiol. 2006]Plant Cell. 2003 Mar; 15(3):732-44.
[Plant Cell. 2003]EMBO J. 2004 Apr 7; 23(7):1587-97.
[EMBO J. 2004]Annu Rev Immunol. 2005; 23():387-414.
[Annu Rev Immunol. 2005]EMBO J. 2002 Sep 2; 21(17):4511-9.
[EMBO J. 2002]Plant Physiol. 2006 Apr; 140(4):1233-45.
[Plant Physiol. 2006]EMBO J. 2000 Aug 1; 19(15):4004-14.
[EMBO J. 2000]Proc Natl Acad Sci U S A. 2003 Jun 24; 100(13):8024-9.
[Proc Natl Acad Sci U S A. 2003]Proc Natl Acad Sci U S A. 2006 Jun 6; 103(23):8888-93.
[Proc Natl Acad Sci U S A. 2006]Cell. 2002 Mar 22; 108(6):743-54.
[Cell. 2002]Cell. 2003 Feb 7; 112(3):379-89.
[Cell. 2003]Plant J. 2002 Oct; 32(2):195-204.
[Plant J. 2002]EMBO J. 2002 Sep 2; 21(17):4511-9.
[EMBO J. 2002]Plant J. 2000 Jan; 21(1):73-81.
[Plant J. 2000]Plant J. 2002 Mar; 29(5):569-79.
[Plant J. 2002]